Alkotinib
ALK-positive Non-small Cell Lung Cancer
Suzhou Zelgen Biopharmaceuticals Co.,LtdPhase 2
—
Rating in progress
Alkotinib in ALK-positive Non-small Cell Lung Cancer is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Dormant